This topic contains a solution. Click here to go to the answer

Author Question: In terms of learning about generalization across participants, a. the researcher can normally be ... (Read 182 times)

Chelseaamend

  • Hero Member
  • *****
  • Posts: 545
In terms of learning about generalization across participants,
 
  a. the researcher can normally be confident that a result found in one sample will generalize to all populations that he or she is interested in.
  b. the researcher can usually be confident that a result found in one sample will not generalize beyond the sample that he or she has studied.
  c. no sample of research participants can provide definitive information about how a finding will generalize.
  d. it is possible to make highly accurate statements about the likelihood of a finding generalizing to all populations.

Question 2

The degree to which relationships among conceptual variables can be demonstrated in a wide variety of people and using a wide variety of manipulated or measured variables is known as which of the following?
 
  a. Conceptual replication
  b. External validity
  c. Ecological validity
  d. Meta analysis



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

fauacakatahaias

  • Sr. Member
  • ****
  • Posts: 353
Answer to Question 1

c

Answer to Question 2

b





 

Did you know?

In the United States, there is a birth every 8 seconds, according to the U.S. Census Bureau's Population Clock.

Did you know?

Carbamazepine can interfere with the results of home pregnancy tests. If you are taking carbamazepine, do not try to test for pregnancy at home.

Did you know?

Since 1988, the CDC has reported a 99% reduction in bacterial meningitis caused by Haemophilus influenzae, due to the introduction of the vaccine against it.

Did you know?

Street names for barbiturates include reds, red devils, yellow jackets, blue heavens, Christmas trees, and rainbows. They are commonly referred to as downers.

Did you know?

The Food and Drug Administration has approved Risperdal, an adult antipsychotic drug, for the symptomatic treatment of irritability in children and adolescents with autism. The approval is the first for the use of a drug to treat behaviors associated with autism in children. These behaviors are included under the general heading of irritability and include aggression, deliberate self-injury, and temper tantrums.

For a complete list of videos, visit our video library